US open: Stocks flat amid dovish Fedspeak

Alexander Bueso Sharecast | 12 Oct, 2017 18:42 | | |

actasfed

Wall Street is trading on a mixed note as traders take some money off the table following the latest earnings updates out of Citigroup and JP Morgan and somewhat dovish remarks by a trio of top Fed officials.

As of 1815 BST, the Dow Industrials was dipping 0.01% or 1.83 points to 22,870.65, alongside a 0.3% or 0.85 point drop for the S&P 500 to 2,554.45.

From a sector standpoint, the worst performing areas of the market were: Fixed Line Telecommunications (-2.81%), Telecommunications (-2.66%) and Broadcasting (-1.82%).

The KBW index of banks' shares was also weaker, giving back 0.62% to 99.80 points.

Weighing on lenders perhaps, speaking at the annual meeting of the International Monetary Fund and World Bank, US Federal Reserve governor Lael Brainard reportedly said that US inflationary headwinds now appeared to be "a little more" structural than cyclical.

She also noted that a persistently low neutral interest rate had "big implications".

On the other hand, another Fed governor, Jerome Powell, indicated that policy tightening should remain gradual so long as the economy evolved as anticipated.

Acting as a backdrop, overnight the minutes of the US central bank's last policy meeting had indicated that "many participants" had shown concern that low inflation readings might not only reflect transitory factors. Yet in parallel, some market observers are wary of lofty valuations even for benchmarks such as the S&P 500.

To take note of as well, according to coindesk the price of Bitcoins hit a new all-time high on Thursday of $5,281.59.

In economic news, initial jobless claims in the US fell by 15,000 over the week ending on 7 October to reach 243,000 (consensus: 250,000), according to the Bureau of Labor Statistics.

Wholesale prices advanced at a 0.4% month-on-month and 2.6% yaer-on-year clip last month, as forecast by economists.

On the corporate front, shares of Citi were losing ground despite reporting third quarter earnings per share of $1.42 (consensus: $1.32) on the back of $18.2bn in revenues (consensus: $17.9bn).

Shares of JP Morgan were also trading on the back foot - although they were just off their 52-week highs - even after posted better than expected EPS for the latest three-month stretch, albeit alongside falling market revenues and higher credit loss provisions.

Dow Jones - Risers

Microsoft Corp. (MSFT) $77.14 0.94%
Caterpillar Inc. (CAT) $129.57 0.76%
United Technologies Corp. (UTX) $118.45 0.59%
Wal-Mart Stores Inc. (WMT) $86.23 0.58%
Procter & Gamble Co. (PG) $91.96 0.55%
McDonald's Corp. (MCD) $163.99 0.51%
Boeing Co. (BA) $262.51 0.41%
Travelers Company Inc. (TRV) $125.95 0.27%
Apple Inc. (AAPL) $156.90 0.22%
3M Co. (MMM) $216.96 0.21%

Dow Jones - Fallers

Walt Disney Co. (DIS) $97.15 -1.42%
Nike Inc. (NKE) $50.53 -0.99%
Verizon Communications Inc. (VZ) $48.43 -0.88%
JP Morgan Chase & Co. (JPM) $96.24 -0.62%
Cisco Systems Inc. (CSCO) $33.40 -0.57%
Unitedhealth Group Inc. (UNH) $194.23 -0.53%
Goldman Sachs Group Inc. (GS) $241.36 -0.43%
General Electric Co. (GE) $22.99 -0.37%
Exxon Mobil Corp. (XOM) $82.34 -0.31%
Home Depot Inc. (HD) $164.84 -0.25%

S&P 500 - Risers

Host Hotels & Resorts Inc. (HST) $19.34 3.59%
W.W. Grainger Inc. (GWW) $176.87 2.53%
Fastenal Co. (FAST) $45.60 2.45%
CF Industries Holdings Inc. (CF) $35.73 2.35%
United States Steel Corp. (X) $25.78 2.32%
Blackrock Inc. (BLK) $484.65 2.26%
XL Group Ltd (XL) $40.24 2.25%
Kellogg Co. (K) $62.50 2.04%
ConAgra Brands Inc (CAG) $34.47 2.03%
T. Rowe Price Group Inc. (TROW) $94.71 2.00%

S&P 500 - Fallers

Endo International Plc (ENDP) $8.35 -7.02%
Juniper Networks Inc. (JNPR) $25.27 -5.92%
AT&T Inc. (T) $36.46 -4.53%
Bed Bath & Beyond Inc. (BBBY) $21.16 -3.80%
Helmerich & Payne Inc. (HP) $50.50 -3.40%
Diamond Offshore Drilling Inc. (DO) $14.49 -3.40%
Urban Outfitters Inc. (URBN) $22.22 -3.39%
Comcast Corp. (CMCSA) $36.20 -3.26%
Chesapeake Energy Corp. (CHK) $3.82 -3.18%
TEGNA Inc (TGNA) $12.55 -3.09%

Nasdaq 100 - Risers

Idexx Laboratories Inc. (IDXX) $162.86 3.02%
Fastenal Co. (FAST) $45.60 2.45%
J.B. Hunt Transport Services Inc. (JBHT) $107.58 1.80%
Citrix Systems Inc. (CTXS) $81.87 1.61%
Symantec Corp. (SYMC) $32.10 1.56%
Activision Blizzard Inc. (ATVI) $62.23 1.42%
Paypal Holdings Inc (PYPL) $68.74 1.41%
Applied Materials Inc. (AMAT) $53.91 1.28%
NetEase Inc. Ads (NTES) $272.23 1.28%
CSX Corp. (CSX) $53.72 1.22%

Nasdaq 100 - Fallers

Mercadolibre Inc. (MELI) $248.68 -9.40%
Ulta Salon, Cosmetics & Fragrance Inc. (ULTA) $194.15 -6.61%
Dish Network Corp. (DISH) $48.88 -5.36%
Comcast Corp. (CMCSA) $36.20 -3.26%
Discovery Communications Inc. Class A (DISCA) $19.41 -2.95%
Viacom Inc. Class B (VIAB) $24.50 -2.84%
Discovery Communications Inc. Class C (DISCK) $18.41 -2.75%
JD.com, Inc. (JD) $38.61 -2.55%
Liberty Global Plc Lilac Class C (LILAK) $22.87 -2.39%
Tractor Supply Company (TSCO) $58.10 -2.24%

More news

08:24 Capita's sale of Asset Services arm nears completion

Capita expects to complete the sale of its Asset Services businesses to Link Administration a week on Friday.

08:21 Pendragon warns on profit amid weaker new car demand

Car dealership Pendragon warned on Monday that full-year profit will be hit by weaker new car demand and pricing on used cars, as it announced that chairman Mel Egglenton has stepped down with immediate effect.

08:03 Electra Private Equity eyes new flexible approach, declares another dividend

After completing a strategic review and reverted to internal management of its investments, Electra Private Equity has decided "current market conditions do not support new investment" and so proposed handing back most of its cash and dropping its focus on private equity to become "more flexible".

08:02 CRH gets shareholder approval for Ash Grove deal

Building materials company CRH is set to push ahead with its $3.5bn acquisition of US cement manufacturer Ash Grove Cement after receiving shareholder approval for the deal.

07:51 AstraZeneca diabetes drug gets FDA approval

AstraZeneca said that the US Food and Drug Administration has approved a new formulation of its type-2 diabetes treatment Bydureon.

07:41 GlaxoSmithKline's Shingrix gets US FDA approval

GlaxoSmithKline said on Monday that the US Food and Drug Administration has approved Shingrix for the prevention of shingles in adults over 50.

07:38 Renewi sees full-year results 'significantly above' previous expectations

Waste-to-product business Renewi said on Monday that results for the year are expected to be “significantly above” its previous expectations following a particularly strong performance in September.

07:33 London pre-open: Stocks to nudge lower as pound gains ground

London stocks were set to nudge a touch lower at the open on Monday as the pound gains ground against the dollar and the euro.

07:31 Spire rejects rival's advances, Renewi raises expectations

London open The FTSE 100 is expected to gain roughly six points on Monday, according to traders in the City, having closed the prior week at 7,523.23.

07:20 Spire Healthcare rebuffs offer from Mediclinic

Spire Healthcare has rejected a cash-and-shares offer from fellow private hospital operator Mediclinic International.